Clinical Trials Directory

Trials / Completed

CompletedNCT05191251

Retrospective Assessment of the Risk of Peripartum Hemorrhage in Pregnant Women : Retrospective Assessment of the Diagnostic Performance of the HEMSTOP Standardized Questionnaire

Status
Completed
Phase
Study type
Observational
Enrollment
3,588 (actual)
Sponsor
Brugmann University Hospital · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers

Summary

The diagnostic performance of the HEMSTOP (Hematoma, hEmorrhage, Menorrhagia, Surgery, Tooth extraction, Obstetrics, Parents) standardized questionnaire collected during the preoperative anesthesia consultation in order to detect a deficit in hemostasis associated with the risk of hemorrhage in pregnant women will be analyzed. The primary aim of the study is to assess the sensitivity and the specificity of the HEMSTOP questionnaire to identity patients with an abnormal first-line hemostasis test requiring further development by performing second-line hemostasis tests. The second aim of the study is to assess the sensitivity and specificity of the HEMSTOP questionnaire in predicting postpartum hemorrhage.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTHEMSTOP questionnaireA HEMSTOP questionnaire is obtained during the anesthesia consultation.

Timeline

Start date
2022-01-13
Primary completion
2022-06-10
Completion
2022-06-30
First posted
2022-01-13
Last updated
2022-07-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05191251. Inclusion in this directory is not an endorsement.